期刊文献+

老年肥胖高血压患者白介素-18、-10水平及其比值变化的临床意义 被引量:2

The clinical significance of IL-18,IL-10 and IL-18/IL-10 changes in aged patients with obesity and hypertension
下载PDF
导出
摘要 目的探讨老年肥胖高血压患者血浆白细胞介素-18(IL-18)、白细胞介素-10(IL-10)及其比值的变化和临床意义。方法纳入116例老年肥胖高血压患者(实验组)和116例老年非肥胖高血压患者(对照组),检测两组患者血脂、血糖、胰岛素,计算胰岛素抵抗指数,采用酶联免疫吸附(ELISA)法检测其血清IL-18、IL-10等浓度变化。结果老年肥胖高血压患者胰岛素抵抗指数、血浆IL-18、IL-10水平及其比值明显高于老年非肥胖高血压患者(P<0.01或P<0.05)。结论老年肥胖高血压患者血浆IL-18升高,IL-18与抗炎因子IL-10比例失调,可能加重老年肥胖高血压患者动脉粥样硬化的进展过程。 Objective To investigate the changes of plasma interleukin-18(IL-18),interleukin-10(IL-10)and IL-18/IL-10 ratio in aged patients with obesity and hypertension and the clinical significance.Methods 116 aged patients with obesity and hypertension and 116sex and age matched controls(aged patients with hypertension but not obesity)were enrolled in the study.Blood lipid,glucose and insulin were investigated and the insulin resistance index was calculated.Plasma IL-18 and IL-10 concentrations were measured by enzyme-linked immunosorbent assay(ELISA).Results The insulin resistance index,plasma IL-18,IL-10 and IL-18/Il-10 ratio in aged patients with obesity and hypertension were significantly higher than that in control subjects(P〈0.01or P〈0.05).Conclusion The elevation of IL-18 and IL-18/Il-10 ratio may accelerate the process of atherosclerosis in aged patients with obesity and hypertension.
出处 《西部医学》 2014年第7期833-835,共3页 Medical Journal of West China
基金 国家自然科学基金(81170081)
关键词 原发性高血压 肥胖 炎症 白细胞介素 Primary hypertension Obesity Inflammation Interleukin
  • 相关文献

参考文献12

  • 1Legein B, Temmerman L, Biessen EA, et al. Inflammation andimmune system interactions in atherosclerosis [J]. Ceil Mol LifeSci, 2013, 70(20): 3847-3869.
  • 2中国髙血压防治指南修订委员会.中国髙血压防治指南2010[J].中华髙血压杂志,2011,19(8):701 -743.
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4Rahmouni K, Correia ML,Haynes WG,et al. Obesity-associ-ated hypertension: new insights into mechanisms[J], Hyperten-sion, 2005’ 45(1): 9-14.
  • 5Marinou K* Tousoulis D, Antonopoulos AS* et al. Obesity andcardiovascular disease: from pathophysiology to risk stratifica-tion[J]. Int J Cardiol, 2010, 138(1): 3-8.
  • 6Poulos SP,Hausman DB, Hausman GJ. The development andendocrine functions of adipose tissue [J]. Mol Cell Endocrinol,2010, 323(1): 20-34.
  • 7Hansson GK, Hermansson A. The immune system in athero-scIerosis[J]. Nat Immunol, 201 f 12(3) :204-212.
  • 8Badimon L. Interleukin-18 : a potent pro-inflammatory cytokinein atherosclerosis [J]. Cardiovasc Res. 2012,96(2) : 172-175.
  • 9Blankenberg S,Tiret L, Bickei C, et al. Interleukin-18 is astrong predictor o. cardiovascular death in stable and unstableangina[J]. Circulation, 2002,106(1) : 24-30.
  • 10Chalikias GK, Tziakas DN, KaskiJC, et al. Interleukin-18 : in-terleukin-10 ratio and in-hospital adverse events in patients withacute coronary syndrome [J]. Atherosclerosis. 2005,182(1):135-143.

二级参考文献149

共引文献5234

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部